{
  "approved_at_utc": null,
  "subreddit": "investing",
  "selftext": "Will be separating it's consumer division from it's pharmaceutical and medical device division. What's everyone's take on this new direction?   Johnson and Johnson is the world's largest health products companies by sales but believes that the two divisions directions and growth are diverging rapidly. \n     Is this the right direction for them to take?   No decision yet one what they will do when it comes to holding a stock offering.  \n     I've always felt J n J was a safe long term hold how does this change that now?  More growth potential with the pharmaceutical division but comes with more risk too.  As the WSJ article states the consumer division comes with its own  issues,  as it's  \"Sales are growing more slowly than at the other businesses, and have lower margins too. \"",
  "author_fullname": "t2_6b00ty40",
  "saved": false,
  "mod_reason_title": null,
  "gilded": 0,
  "clicked": false,
  "title": "Johnson and Johnson planning on splitting into two separate companies!",
  "link_flair_richtext": [],
  "subreddit_name_prefixed": "r/investing",
  "hidden": false,
  "pwls": 6,
  "link_flair_css_class": null,
  "downs": 0,
  "top_awarded_type": null,
  "hide_score": false,
  "name": "t3_qs9jsv",
  "quarantine": false,
  "link_flair_text_color": "dark",
  "upvote_ratio": 0.89,
  "author_flair_background_color": null,
  "subreddit_type": "public",
  "ups": 1038,
  "total_awards_received": 0,
  "media_embed": {},
  "author_flair_template_id": null,
  "is_original_content": false,
  "user_reports": [],
  "secure_media": null,
  "is_reddit_media_domain": false,
  "is_meta": false,
  "category": null,
  "secure_media_embed": {},
  "link_flair_text": null,
  "can_mod_post": false,
  "score": 1038,
  "approved_by": null,
  "is_created_from_ads_ui": false,
  "author_premium": false,
  "thumbnail": "",
  "edited": false,
  "author_flair_css_class": null,
  "author_flair_richtext": [],
  "gildings": {},
  "content_categories": null,
  "is_self": true,
  "mod_note": null,
  "created": 1636717933,
  "link_flair_type": "text",
  "wls": 6,
  "removed_by_category": null,
  "banned_by": null,
  "author_flair_type": "text",
  "domain": "self.investing",
  "allow_live_comments": true,
  "selftext_html": "<!-- SC_OFF --><div class=\"md\"><p>Will be separating it&#39;s consumer division from it&#39;s pharmaceutical and medical device division. What&#39;s everyone&#39;s take on this new direction?   Johnson and Johnson is the world&#39;s largest health products companies by sales but believes that the two divisions directions and growth are diverging rapidly. \n     Is this the right direction for them to take?   No decision yet one what they will do when it comes to holding a stock offering.<br/>\n     I&#39;ve always felt J n J was a safe long term hold how does this change that now?  More growth potential with the pharmaceutical division but comes with more risk too.  As the WSJ article states the consumer division comes with its own  issues,  as it&#39;s  &quot;Sales are growing more slowly than at the other businesses, and have lower margins too. &quot;</p>\n</div><!-- SC_ON -->",
  "likes": null,
  "suggested_sort": null,
  "banned_at_utc": null,
  "view_count": null,
  "archived": false,
  "no_follow": false,
  "is_crosspostable": false,
  "pinned": false,
  "over_18": false,
  "awarders": [],
  "media_only": false,
  "can_gild": false,
  "spoiler": false,
  "locked": false,
  "author_flair_text": null,
  "treatment_tags": [],
  "visited": false,
  "removed_by": null,
  "num_reports": null,
  "distinguished": null,
  "subreddit_id": "t5_2qhhq",
  "author_is_blocked": false,
  "mod_reason_by": null,
  "removal_reason": null,
  "link_flair_background_color": "",
  "id": "qs9jsv",
  "is_robot_indexable": true,
  "report_reasons": null,
  "author": "Campfireandhotcocoa",
  "discussion_type": null,
  "num_comments": 46,
  "send_replies": true,
  "whitelist_status": "all_ads",
  "contest_mode": false,
  "mod_reports": [],
  "author_patreon_flair": false,
  "author_flair_text_color": null,
  "permalink": "/r/investing/comments/qs9jsv/johnson_and_johnson_planning_on_splitting_into/",
  "parent_whitelist_status": "all_ads",
  "stickied": false,
  "url": "https://www.reddit.com/r/investing/comments/qs9jsv/johnson_and_johnson_planning_on_splitting_into/",
  "subreddit_subscribers": 1946895,
  "created_utc": 1636725400,
  "num_crossposts": 0,
  "media": null,
  "is_video": false,
  "original_created_utc": 1636717933,
  "the_new_excerpt": "Will be separating it's consumer division from it's pharmaceutical and medical\ndevice division. What's everyone's take on this new direction? Johnson and\nJohnson is the world's largest health products companies by sales but believes\nthat the two divisions directions and growth are diverging rapidly.…",
  "localize": [
    {
      "locale": "ja",
      "the_new_excerpt": "コンシューマー部門と医薬・医療機器部門を分離します。\nこの新しい方向性について、皆さんはどう思われますか？この新しい方向性について、皆さんはどのようにお考えですか？ジョンソン・アンド・ジョンソン\nジョンソン・アンド・ジョンソンは、売上高では世界最大の健康食品会社ですが、2つの部門の方向性と成長については\nこの2つの部門の方向性と成長は急速に乖離していると考えている....",
      "title": "ジョンソン・アンド・ジョンソンが2つの会社に分割することを計画中!"
    },
    {
      "locale": "zh",
      "the_new_excerpt": "将把它的消费者部门与它的制药和医疗设备部门分开。\n器械部门。大家对这个新方向有什么看法？强生公司\n强生公司是世界上销售额最大的健康产品公司，但认为\n这两个部门的方向和增长正在迅速分化....。",
      "title": "强生公司计划分拆为两个独立的公司!"
    },
    {
      "locale": "zh-Hant",
      "the_new_excerpt": "將把它的消費者部門與它的製藥和醫療設備部門分開。\n器械部門。大家對這個新方向有什麼看法？強生公司\n強生公司是世界上銷售額最大的健康產品公司，但認爲\n這兩個部門的方向和增長正在迅速分化....。",
      "title": "強生公司計劃分拆爲兩個獨立的公司!"
    }
  ],
  "source_updated_at": 1637314882638
}